Proof of Concept (POC) in Patients With Ischaemic Stroke

Summary

Study MAG104615, a Proof of Concept Study for GSK249320 versus placebo in Stroke Patients.

Timeline

Start

2013-05-18

Primary completion

2014-07-28

Completion

2014-07-28

Outcome

Outcome not reported

Stopped: “This study was terminated for futility.”

Publications

• Cramer SC, Enney LA, Russell CK, Simeoni M, Thompson TR. Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients. Stroke. 2017 Mar;48(3):692-698. doi: 10.1161/STROKEAHA.116.014517. Epub 2017 Feb 22.

Drugs

Indications